Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 3/20 | 0.42 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.37 |
| ▸ | KCNH2 known ✓ | Q12809 | 2/20 | 0.35 |
| ▸ | ACE known ✓ | P12821 | 1/20 | 0.34 |
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.33 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maleic Acid SCHEMBL6589525 | 1.00 | SLC6A2 (0.42) | SLC6A2HTR2ALMNABLMKCNH2 | |
| Maleic Acid SCHEMBL6589717 | 0.91 | SLC6A2 (0.39) | SLC6A2HTR2ALMNABLMKCNH2 | |
| Fumaric Acid SCHEMBL6592830 | 0.91 | SLC6A2 (0.39) | SLC6A2HTR2ALMNABLMKCNH2 | |
| SCHEMBL6592097 | 0.89 | EED (0.38) | SLC6A2HTR2ALMNAKCNH2MEN1 | |
| Fumaric Acid SCHEMBL8433463 | 0.86 | HRH1 (0.42) | SLC6A2HTR2ALMNABLML3MBTL1 | |
| Maleic Acid SCHEMBL8433458 | 0.86 | HRH1 (0.42) | SLC6A2HTR2ALMNABLML3MBTL1 | |
| Maleic Acid SCHEMBL6589825 | 0.85 | ESR1 (0.37) | SLC6A2LMNABLMKCNH2ACE | |
| Fumaric Acid SCHEMBL6592056 | 0.85 | ESR1 (0.37) | SLC6A2LMNABLMKCNH2ACE | |
| Fumaric Acid SCHEMBL6587762 | 0.82 | LMNA (0.40) | SLC6A2LMNABLMKCNH2HTT | |
| Fumaric Acid SCHEMBL6587770 | 0.82 | LMNA (0.40) | SLC6A2LMNABLMKCNH2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0703232-B1 | 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors | AVENTIS PHARMA INC (US) | 2004-06-30 | — | — | EP | claimed |
| US-5567718-A | PSYCHOLOGICAL DISORDERS | HOECHST MARION ROUSSEL INC. (US) | 1996-10-22 | — | — | US | claimed |
| EP-0703232-A2 | 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1996-03-27 | — | — | EP | claimed |
| EP-0703232-B1 | 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors | AVENTIS PHARMA INC (US) | 2004-06-30 | — | — | EP | disclosed |
| US-5874458-A | PSYCHOLOGICAL DISORDERS | HOECHST MARION ROUSSEL INC. (US) | 1999-02-23 | — | — | US | disclosed |
| US-5874583-A | TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, STUTTERING, TRICHOTILLOMANIA | HOECHST MARION ROUSSEL INC. (US) | 1999-02-23 | — | — | US | disclosed |
| US-5869685-A | SEROTONIN REUPTAKE INHIBITORS | HOECHST MARION ROUSSEL INC. (US) | 1999-02-09 | — | — | US | disclosed |
| US-5869502-A | TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, STUTTERING, TRICHOTILLOMANIA | HOECHST MARION ROUSSEL INC. (US) | 1999-02-09 | — | — | US | disclosed |
| US-5567718-A | PSYCHOLOGICAL DISORDERS | HOECHST MARION ROUSSEL INC. (US) | 1996-10-22 | — | — | US | disclosed |
| EP-0703232-A2 | 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1996-03-27 | — | — | EP | disclosed |